Jubilant Pharmova Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Pharmova Limited has submitted a routine compliance certificate to the stock exchanges for the quarter ended June 30, 2025. The certificate was issued by Alankit Assignments Limited, the company's Registrar and Share Transfer Agent, under SEBI's Depositories Regulations. It confirms that physical share certificates received from shareholders for converting into demat form (dematerialization) were properly listed, verified, cancelled, and the depository was recorded as the new registered owner. This is a standard quarterly regulatory filing required under Regulation 74(5).
This is a routine administrative compliance filing with no material impact on the company's business, financials, or share price. It simply confirms proper processing of physical-to-demat share conversions during the quarter.